ARYZTA Future Growth

Future criteria checks 3/6

ARYZTA is forecast to grow earnings and revenue by 16.9% and 3.3% per annum respectively. EPS is expected to grow by 19.4% per annum. Return on equity is forecast to be 33.2% in 3 years.

Key information

16.9%

Earnings growth rate

19.4%

EPS growth rate

Food earnings growth13.4%
Revenue growth rate3.3%
Future return on equity33.2%
Analyst coverage

Low

Last updated08 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:ARZT.Y - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,337123N/A2693
12/31/20252,262111N/A2603
12/31/20242,217104N/A2561
6/30/20242,14573142220N/A
3/31/20242,14871158229N/A
12/31/20232,15068174239N/A
7/29/20232,12365188251N/A
4/29/20232,04156183259N/A
1/28/20231,95847179266N/A
10/28/20221,8572145233N/A
7/30/20221,756-43111200N/A
4/29/20221,682-6631116N/A
1/29/20221,608-88-4931N/A
10/29/20211,567-92-2658N/A
7/31/20211,525-96-484N/A
4/30/20211,497-150-4343N/A
1/30/20211,469-204-831N/A
10/30/20201,569-346-8013N/A
8/1/20201,669-489-7624N/A
5/1/20202,147-44639151N/A
1/25/20202,625-402155278N/A
10/25/20193,004-235131245N/A
7/27/20193,383-68107212N/A
4/27/20193,371-19077169N/A
1/31/20193,360-31246127N/A
10/31/20183,398-40755138N/A
7/31/20183,435-50263150N/A
4/30/20183,556-749N/A192N/A
1/31/20183,677-995N/A233N/A
10/31/20173,737-967N/A295N/A
7/31/20173,797-940N/A356N/A
4/30/20173,811-535N/A410N/A
1/31/20173,825-131N/A465N/A
10/31/20163,852-25N/A531N/A
7/31/20163,87981N/A597N/A
4/30/20163,90129N/A538N/A
1/31/20163,922-23N/A479N/A
10/31/20153,871-29N/A381N/A
7/31/20153,820-35N/A283N/A
1/31/20153,14978N/A563N/A
10/31/20143,27170N/A531N/A
7/31/20143,39463N/A499N/A
4/30/20144,67494N/A445N/A
1/31/20144,53882N/A392N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ARZT.Y's forecast earnings growth (16.9% per year) is above the savings rate (2.6%).

Earnings vs Market: ARZT.Y's earnings (16.9% per year) are forecast to grow faster than the US market (15.3% per year).

High Growth Earnings: ARZT.Y's earnings are forecast to grow, but not significantly.

Revenue vs Market: ARZT.Y's revenue (3.3% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: ARZT.Y's revenue (3.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: ARZT.Y's Return on Equity is forecast to be high in 3 years time (33.2%)


Discover growth companies